TrialEuropean journal of clinical pharmacology2025
Efficacy and safety of nitazoxanide and escitalopram as adjuvant therapies in patients with rheumatoid arthritis: a randomized controlled study.
Tarek M Mostafa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.